Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor.
about
Patan hospital experience in treating philadelphia chromosome/BCR-ABL1 positive chronic myeloid leukemia patients with gleevec (imatinib mesylate); the first generation specific tyrosine kinase inhibitor.
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Patan hospital experience in t ...... fic tyrosine kinase inhibitor.
@ast
Patan hospital experience in t ...... fic tyrosine kinase inhibitor.
@en
type
label
Patan hospital experience in t ...... fic tyrosine kinase inhibitor.
@ast
Patan hospital experience in t ...... fic tyrosine kinase inhibitor.
@en
prefLabel
Patan hospital experience in t ...... fic tyrosine kinase inhibitor.
@ast
Patan hospital experience in t ...... fic tyrosine kinase inhibitor.
@en
P2093
P2860
P356
P1433
P1476
Patan hospital experience in t ...... fic tyrosine kinase inhibitor.
@en
P2093
Aaron S Mansfield
Arjun Karki
Bruce Hayes
Buddhi P Paudyal
Gyan K Kayastha
Mark Zimmerman
Padma Gurung
Paras K Acharya
P2860
P2888
P356
10.1186/1471-2326-10-8
P577
2010-12-07T00:00:00Z
P5875
P6179
1025372411